These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 30413999)

  • 1. Immune regulation by protein ubiquitination: roles of the E3 ligases VHL and Itch.
    Aki D; Li Q; Li H; Liu YC; Lee JH
    Protein Cell; 2019 Jun; 10(6):395-404. PubMed ID: 30413999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF-1alpha and EPAS ubiquitination mediated by the VHL tumour suppressor involves flexibility in the ubiquitination mechanism, similar to other RING E3 ligases.
    Paltoglou S; Roberts BJ
    Oncogene; 2007 Jan; 26(4):604-9. PubMed ID: 16862177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The E3 ligases Itch and WWP2 cooperate to limit T
    Aki D; Li H; Zhang W; Zheng M; Elly C; Lee JH; Zou W; Liu YC
    Nat Immunol; 2018 Jul; 19(7):766-775. PubMed ID: 29925997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E3 Ligase VHL Promotes Group 2 Innate Lymphoid Cell Maturation and Function via Glycolysis Inhibition and Induction of Interleukin-33 Receptor.
    Li Q; Li D; Zhang X; Wan Q; Zhang W; Zheng M; Zou L; Elly C; Lee JH; Liu YC
    Immunity; 2018 Feb; 48(2):258-270.e5. PubMed ID: 29452935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E3 ligase VHL promotes follicular helper T cell differentiation via glycolytic-epigenetic control.
    Zhu Y; Zhao Y; Zou L; Zhang D; Aki D; Liu YC
    J Exp Med; 2019 Jul; 216(7):1664-1681. PubMed ID: 31123085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein.
    Groulx I; Lee S
    Mol Cell Biol; 2002 Aug; 22(15):5319-36. PubMed ID: 12101228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ubiquitin system in immune regulation.
    Park Y; Jin HS; Aki D; Lee J; Liu YC
    Adv Immunol; 2014; 124():17-66. PubMed ID: 25175772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The E3 ligase Itch in immune regulation and beyond.
    Aki D; Zhang W; Liu YC
    Immunol Rev; 2015 Jul; 266(1):6-26. PubMed ID: 26085204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The E3 ubiquitin ligase Itch is required for the differentiation of follicular helper T cells.
    Xiao N; Eto D; Elly C; Peng G; Crotty S; Liu YC
    Nat Immunol; 2014 Jul; 15(7):657-66. PubMed ID: 24859451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The E3 ubiquitin ligase Itch in T cell activation, differentiation, and tolerance.
    Liu YC
    Semin Immunol; 2007 Jun; 19(3):197-205. PubMed ID: 17433711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin ligases and the immune response.
    Liu YC
    Annu Rev Immunol; 2004; 22():81-127. PubMed ID: 15032575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drosophila von Hippel-Lindau tumor suppressor complex possesses E3 ubiquitin ligase activity.
    Aso T; Yamazaki K; Aigaki T; Kitajima S
    Biochem Biophys Res Commun; 2000 Sep; 276(1):355-61. PubMed ID: 11006129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer.
    Satija YK; Bhardwaj A; Das S
    Int J Cancer; 2013 Dec; 133(12):2759-68. PubMed ID: 23436247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the C-terminal alpha-helical domain of the von Hippel-Lindau protein in its E3 ubiquitin ligase activity.
    Lewis MD; Roberts BJ
    Oncogene; 2004 Mar; 23(13):2315-23. PubMed ID: 14691445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein.
    Li Z; Na X; Wang D; Schoen SR; Messing EM; Wu G
    J Biol Chem; 2002 Feb; 277(7):4656-62. PubMed ID: 11739384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of E3 ligases in autoimmunity and the regulation of autoreactive T cells.
    Lin AE; Mak TW
    Curr Opin Immunol; 2007 Dec; 19(6):665-73. PubMed ID: 18036806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitination system and autoimmunity: the bridge towards the modulation of the immune response.
    Gómez-Martín D; Díaz-Zamudio M; Alcocer-Varela J
    Autoimmun Rev; 2008 Feb; 7(4):284-90. PubMed ID: 18295731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of the catalytic regulation of NEDD4-1 and WWP2 ubiquitin ligases.
    Jiang H; Thomas SN; Chen Z; Chiang CY; Cole PA
    J Biol Chem; 2019 Nov; 294(46):17421-17436. PubMed ID: 31578285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin Ligases in Cancer Immunotherapy - Balancing Antitumor and Autoimmunity.
    Fujita Y; Tinoco R; Li Y; Senft D; Ronai ZA
    Trends Mol Med; 2019 May; 25(5):428-443. PubMed ID: 30898473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex.
    Iwai K; Yamanaka K; Kamura T; Minato N; Conaway RC; Conaway JW; Klausner RD; Pause A
    Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12436-41. PubMed ID: 10535940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.